Homepage zuehlke.com
Venture Partnerships & Investments
Our Investment focus & philosophy
Our goals are to recognize potential, get involved early, limit threats and accept reasonable risks. The many assets Zühlke Ventures provide include sound financing, a wealth of management and technology experience, and our strong network.
Our investment philosophy focuses on:
- Focus: Focus exclusively on early-stage investments in the HealthTech sector.
- Duration: 5 - 8 years
- Geography: Main activity in Switzerland and Europe, complemented by interests in the US.
- Scale: Zühlke Ventures hold a minority stake, with initial investments of CHF 150k – 250k per start-up.
- Cooperations: Proactive, cooperative partnership gives start-up management access to Zühlke Group know-how.
Our companies
Aluna – Health Platform
A doctor-approved health platform to help you and your child track asthma symptoms anytime, anywhere. Aluna is a portable spirometry test device paired with an interactive mobile game kids will love.
Distalmotion – Robotic Surgery
Dexter simplifies suturing and dissection tasks in general surgery, gynecology and urology. Hence, millions of patients can get access to best-in-class minimally invasive care.
Droplette – Transdermal Drug Delivery
Droplette owns IP for a device that enables delivery of drug molecules via the skin (which otherwise represents a natural barrier) - without pain.
Evismo
Diagnostic of cardiac arrhythmia outside of the clinic with minimal impact on everyday life. Intelligent digital cross-linking of the relevant stakeholders. Improvement of access, prevention, therapy and diagnostic for patients with suspicion of cardiac arrhythmia.
FLOW
Medication-free, at home treatment for depression. Offering a combination of brain stimulation through the Flow headset and psychological treatment through the Flow app.
Hystrix Medical – eCommerce for Medical Products
Digital procurement and sales platform in healthcare. Through integration with local ERP systems, processes in procurement and sales become up to 70% more efficient. With the vision of the hub for market information, hystrix acts as a pivot between healthcare providers and suppliers - fast, simple, digital.
Indivi
Digital Biomarkers for understanding, monitoring, and treating chronic conditions. Indivi Digital Biomarkers are currently applied in multiple sclerosis and have potential application in many diseases in neuroscience as well as rare diseases.
Koya
Active compression treatment for lymphedema patients allowing for more flexible and portable treatment at home or on the go.
Noctrix Health – Neuromodulation Therapy
A wearable neuromodulation therapy for treating sleep disorders; initial focus is Restless Legs Syndrome (RLS). The system is paired with a smartphone app that allows for sleep quality tracking & telemedicine applications for MDs.
Tenon – Sacroiliac Joint Implant
Implant for sacroiliac (SI) joint fixation using a minimally invasive technique via an easily accessible incision resulting in a simpler, more efficient surgery which carries fewer risks.
Bottneuro
Bottneuro develops digital biomarkers, brain imaging- and neuromodulation technologies to become the leading provider of diagnosis and treatment of Alzheimer's disease. Products are highly personalised and suited for home use.
Limula
Limula offers a modular solution for on-demand and at-scale manufacturing of gene and cell therapies in a single device.
PeriVision
PeriVision combines artificial intelligence (AI), virtual reality (VR) and the cloud to build the next generation systems to test and understand visual function.
DSwiss – Cloud Data Vault
Digital vaults for personal documents and passwords, technology for digital document delivery and secure file sharing for asset managers and bank clients.
LMD – Mobile Vital Signs Sensor
World's first medical grade, certified vital signs sensor system for smartphones measuring blood pressure, body temperature and heart rate.
